CA2214998A1 - Testing vessel - Google Patents

Testing vessel Download PDF

Info

Publication number
CA2214998A1
CA2214998A1 CA002214998A CA2214998A CA2214998A1 CA 2214998 A1 CA2214998 A1 CA 2214998A1 CA 002214998 A CA002214998 A CA 002214998A CA 2214998 A CA2214998 A CA 2214998A CA 2214998 A1 CA2214998 A1 CA 2214998A1
Authority
CA
Canada
Prior art keywords
vessel
dissolution testing
testing
dissolution
insert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002214998A
Other languages
English (en)
French (fr)
Inventor
Stephen George Barnwell
Stephen John Burns
Simon Higginbottom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2214998A1 publication Critical patent/CA2214998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G01N2013/006Dissolution of tablets or the like

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
CA002214998A 1995-03-10 1996-03-04 Testing vessel Abandoned CA2214998A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9504893.0 1995-03-10
GBGB9504893.0A GB9504893D0 (en) 1995-03-10 1995-03-10 Testing vessel

Publications (1)

Publication Number Publication Date
CA2214998A1 true CA2214998A1 (en) 1996-09-19

Family

ID=10771008

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002214998A Abandoned CA2214998A1 (en) 1995-03-10 1996-03-04 Testing vessel

Country Status (12)

Country Link
EP (1) EP0815427A1 (fi)
JP (1) JPH11503517A (fi)
KR (1) KR19980702844A (fi)
AU (1) AU4885396A (fi)
BR (1) BR9607230A (fi)
CA (1) CA2214998A1 (fi)
FI (1) FI973639A0 (fi)
GB (1) GB9504893D0 (fi)
IL (1) IL117407A0 (fi)
NO (1) NO974156L (fi)
WO (1) WO1996028717A1 (fi)
ZA (1) ZA961920B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725015C2 (de) * 1997-06-13 2002-02-14 Bayer Ag Sinker zur Bestimmung der Freisetzungsgeschwindigkeit von Wirkstoffen
ES2293084T3 (es) * 2002-12-16 2008-03-16 N.V. Organon Recipiente, metodo y aparato para la prueba de disolucion de un dispositivo de administracion farmaceutica.
US7357046B2 (en) 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
TW200732644A (en) * 2005-10-25 2007-09-01 Rohm & Haas Dissolution test equipment and methods for testing having improved filtration system
DE102009042345A1 (de) 2008-10-21 2010-05-12 Levin, Felix, Dr. Testsystem und Verfahren zur schnellen und einfachen Analyse von Substanzen in Flüssikgeiten
DE202008014226U1 (de) 2008-10-21 2010-11-18 Levin, Felix, Dr. Testsystem zur schnellen und einfachen Analyse von Substanzen in Flüssigkeiten
CN109884281B (zh) * 2019-04-12 2023-12-01 中国地质科学院岩溶地质研究所 一种在线监测碳酸盐岩溶蚀的试验装置
JP7390069B1 (ja) * 2022-09-20 2023-12-01 クラシエ株式会社 薬剤の保持具、溶出試験装置、および薬剤の溶出試験方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862042A (en) * 1974-02-27 1975-01-21 Becton Dickinson Co Serum/plasma separator - piston with red-cell trapping surfaces
FR2546628B1 (fr) * 1983-05-27 1987-02-13 Univ Bordeaux Dispositif pour etudier la liberation-dissolution des medicaments a partir des formes pharmaceutiques pateuses
CA1274159A (en) * 1986-06-19 1990-09-18 Joseph K.S. Lee Dissolution cell and method for determining the in- vitro release of a drug
FR2655874B1 (fr) * 1989-12-20 1992-03-13 Prolabo Sa Cellule de dissolution pour solides et appareil d'etude de la cinetique de dissolution la comportant.
ATE218205T1 (de) * 1993-08-06 2002-06-15 Novartis Erfind Verwalt Gmbh Vorrichtung zur simulation des einflusses des lebenden organismus auf die formveraenderung; das zufalls- und aufloeseverhalten bzw. die wirkstoffabgabe einer pharmazeutischen darreichungsform

Also Published As

Publication number Publication date
FI973639A (fi) 1997-09-09
BR9607230A (pt) 1997-11-11
EP0815427A1 (en) 1998-01-07
IL117407A0 (en) 1996-07-23
FI973639A0 (fi) 1997-09-09
AU4885396A (en) 1996-10-02
KR19980702844A (ko) 1998-08-05
MX9706805A (es) 1997-11-29
NO974156D0 (no) 1997-09-09
JPH11503517A (ja) 1999-03-26
WO1996028717A1 (en) 1996-09-19
ZA961920B (en) 1997-09-08
GB9504893D0 (en) 1995-04-26
NO974156L (no) 1997-09-09

Similar Documents

Publication Publication Date Title
Ross et al. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion
Sako et al. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release
TWI257302B (en) Controlled-release of an active substance into a high fat environment
AU707587B2 (en) Composition for enhanced uptake of polar drugs from the colon
Schug et al. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast
CA2214998A1 (en) Testing vessel
Thahera et al. Formulation and evaluation of Norfloxacin gastro retentive drug delivery systems using natural polymers
Burns et al. Development and validation of an in vitro dissolution method for a floating dosage form with biphasic release characteristics
Mason et al. Use of the Dynamic Gastric Model as a tool for investigating fed and fasted sensitivities of low polymer content hydrophilic matrix formulations
Wilde et al. Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel
CN116600791A (zh) 药物制剂
US20040115822A1 (en) Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
JP3965372B2 (ja) 試料錠崩壊装置、それを用いた崩壊試験装置及び崩壊・溶出試験システム、ならびに試料錠崩壊試験方法
Hussain et al. Formulation and evaluation of gastro retentive floating tablets of simvastatin using hydrophilic rate retardant
Kondo et al. Characteristics of the gastric pH profiles of unfed and fed cynomolgus monkeys as pharmaceutical product development subjects
Rivera et al. Characterizing interspecies differences in gastric fluid properties to improve understanding of in vivo oral drug formulation performance
Jadhav et al. Design and In-vitro Evaluation expandable Gastro retentive tablets of Diltiazem Hydrochloride
Nihar et al. Design and development of controlled porosity osmotic tablets of captopril
Kakuk et al. Advances in drug release investigations: Trends and developments for dissolution test media
MXPA97006805A (en) Pru container
CA2955138A1 (en) Method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms
Malvey et al. Development and Evaluation of floating pulsatile drug delivery system of meloxicam
Basit Dissolution testing of solid dosage forms
Satish et al. Design and optimization of fast dissolving tablets containing metoprolol by sublimation method
Lagas et al. Sublingual nitroglycerin: II. In vitro and in vivo availability of Nitrostat® and Nitrobaat® tablets

Legal Events

Date Code Title Description
FZDE Discontinued